NCT00177814View on ClinicalTrials.gov

Piperacillin as a Part of Antibiotic Streamlining in the Intensive Care Unit

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Gram-negative Bacterial Infections
Trial Locations (1)

15213

University of Pittsburgh Medical Center, Pittsburgh

Sponsors

Collaborators (1)

Celgene Corporation
All Listed Sponsors
collaborator

Celgene Corporation

INDUSTRY

lead

University of Pittsburgh

OTHER